Dominant and shared T cell receptor beta chain variable regions of T cells inducing synovial hyperplasia in rheumatoid arthritis. 1999

T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
Molecular Medicine, Osaka University Medical School, Osaka, 565, Japan.

Previously, we demonstrated the presence of at least two distinct subpopulations of patients with rheumatoid arthritis (RA) employing a cell-transfer experiment using severe combined immunodeficient (SCID) mice. One group of patients, whose T cells derived from the rheumatoid joints, induced synovial hyperplasia (SH) in the SCID mice (the positive group). The other group did not display the induction of SH (the negative group). TCR/Vbeta gene usage analysis indicated that some dominant T cell subpopulations were oligoclonally expanding only in the rheumatoid joints, and not in the periphery of the patients of the positive group. Moreover, these T cell subpopulations were not seen in the joints of patients in the negative group or in non-RA patients. In addition, the preferential uses of certain TCR/Vbetas (Vbeta8, Vbeta12, Vbeta13, and Vbeta14) genes were demonstrated in these T cells. In this study, to investigate whether these T cells are driven by a certain antigen(s), the third complementarity determining regions (CDR3s) of TCR/Vbeta, especially Vbeta8 and Vbeta14 PCR products, were cloned and sequenced. As a result, a dominant CDR3 sequence, CASS-PRERAT-YEQ, was found in Vbeta14+ T cells from the rheumatoid joint of a patient (Patient 1) of the positive group with a Vbeta14 skew. The identical CDR3 sequence also predominated in Vbeta14+ T cells from the rheumatoid joint of another patient (Patient 7) of the positive group with a Vbeta14 skew. In addition, in the patients (Patients 4, 7, 8) of the positive group with a Vbeta8 skew, other dominant CDR3 sequences, CASS-ENS-YEQ and CASS-LTEP-DTQ, were found as in the case of Vbeta14. However, no identical CDR3 sequences were detected dominantly in the joints of the patients in the negative group or in non-RA patients. A Vbeta14+ T cell clone (TCL), named G3, with the identical CDR3 sequence, CASS-PRERAT-YEQ, was isolated successfully from Patient 1, and cell transfer of G3 with autologous irradiated peripheral mononuclear cells induced SH in the SCID mice. Taken together, these results suggest that T cells inducing SH, thought to be pathogenic for RA, might be driven by a certain shared antigen(s).

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013583 Synovial Membrane The inner membrane of a joint capsule surrounding a freely movable joint. It is loosely attached to the external fibrous capsule and secretes SYNOVIAL FLUID. Synovium,Membrana Synovialis Capsulae Articularis,Membrane, Synovial,Membranes, Synovial,Synovial Membranes
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
December 1993, Proceedings of the National Academy of Sciences of the United States of America,
T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
July 1993, Clinical immunology and immunopathology,
T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
December 1988, Arthritis and rheumatism,
T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
April 1995, Human immunology,
T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
June 1987, Scandinavian journal of immunology,
T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
September 1992, European journal of immunology,
T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
February 1993, Bollettino della Societa italiana di biologia sperimentale,
T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
January 1984, Nature,
T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
May 1993, Annals of the rheumatic diseases,
T Mima, and S Ohshima, and M Sasai, and K Nishioka, and M Shimizu, and N Murata, and R Yasunami, and H Matsuno, and M Suemura, and T Kishimoto, and Y Saeki
December 1991, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!